Literature DB >> 28249281

Obesity and Kidney Disease: Hidden Consequences of the Epidemic.

Csaba P Kovesdy1, Susan L Furth, Carmine Zoccali.   

Abstract

Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease, and also for chronic kidney disease. A high body mass index is one of the strongest risk factors for new-onset chronic kidney disease. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing chronic kidney disease in the long-term. The incidence of obesity-related glomerulopathy has increased 10-fold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year, the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that make preventive behaviors an affordable option. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=458481.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 28249281     DOI: 10.1159/000458481

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  2 in total

1.  Antihypertensive Effectiveness of Perindopril Arginine and Indapamide Single-Pill Combination According to Body Mass Index: Findings from the FORSAGE Study.

Authors:  M G Glezer
Journal:  Cardiol Ther       Date:  2020-02-01

2.  Preferences for Sweet and Fatty Taste in Children and Their Mothers in Association with Weight Status.

Authors:  Grzegorz Sobek; Edyta Łuszczki; Mariusz Dąbrowski; Katarzyna Dereń; Joanna Baran; Aneta Weres; Artur Mazur
Journal:  Int J Environ Res Public Health       Date:  2020-01-15       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.